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In Review: Influenza A Virus Hemagglutinin-Glycan Receptor Interactions
PAGE 803
The variety of biological processes is mediated by protein-glycan interactions, including the host-pathogen communication. In this
case, pathogens have evolved various strategies to recognize host cell surface glycans. This review by Shriver et al. now focuses on
the binding of influenza A hemagglutinin (HA) to specific sialylated glycans on the human cell surface as an illustrative example of
protein-glycan interactions and discusses strategies used to extract valuable biochemical, structural, and functional information
that can be generalized for other protein-glycan systems. This can be effectively achieved by combining a top-down approach,
based on the available structural information, with a bottom-up approach, based on data mining and informatics. The review high-
lights the synergistic value of combining new technologies for glycomicswith computational modeling to extend our understanding of
protein-glycan interactions.
Living it Up in the ‘‘RNA WORLD’’
PAGE 815
The most straightforward version of the ‘‘RNA World’’ hypothesis assumes that RNA was the
initial polymer responsible for life. The capability of all living systems to grow exponentially
implies that significant selective pressure to evolve newmetabolic pathways would have existed
as prebiotic supplies of complex nutrients were consumed. Here Lau and Unrau show that
a promiscuous ribozyme selected for its ability to promote Schiff base chemistry with ribose
can also mediate nucleotide synthesis without a single change to its sequence. This catalytic
flexibility supports the assumption that ribo-organisms could have rapidly evolved new meta-
bolic functionalities early in the history of evolution. (Figure credit: Lau and Unrau.)
Fitness Test for Staph Challengers
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The need to discover new antibacterial drugs is a pressing world-wide problem exasperated
by the difficulty in finding attractive new chemical leads that work through target-specific mech-
anisms in the whole cell. The study by Donald et al. describes a chemical genetics platform
developed in the bacterial pathogen Staphylococcus aureus that produces information-rich
strain sensitivity profiles that reflect a compound’s whole-cell mechanism of action (MOA).
The platform has broad applications for the field of antibacterial drug discovery, including
MOA determination for newly discovered antibacterial agents, the identification of novel drug targets, and the elucidation of reporter
strains for pathway-specific screens.
MRSA Meets Its Match
PAGE 837
As noted in the related report by Donald et al., combating bacterial infections by using currently available antibiotics is becoming
increasingly challenging in light of the emergence of drug resistance among the pathogens. Here, Huber et al. describe a chemical
biology approach to identify small molecules that display intrinsic antibacterial activity and uniquely potentiate the effects of b-lactam
antibiotics against methicillin-resistant Staphylococcus aureus (MRSA). Mecha-
nism-of-action studies demonstrate that two structurally related agents identified
from the screen inhibit cell wall biosynthesis and likely act through SAV1754, an
essential protein that the authors propose functions as a peptidoglycan flippase
required for cell wall assembly. These results suggest that SAV1754 inhibitors
may possess therapeutic potential alone or in combination with b-lactams to
restore MRSA efficacy.
NAD Biosynthesis Under Attack
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Biosynthesis of NAD cofactor is one of the most conserved pathways in bacterial
pathogens, and several downstream NAD biosynthetic enzymes are promising
drug targets. In this work, Sorci et al. validate nicotinate mononucleotide adeny-
lyltransferase of the NadD family as a target for broad-spectrum antimicrobial
development by combining comparative genomics with a structure-based
approach. Small-molecule inhibitors targeting NadD from divergent bacteria
were identified and shown to bind in the area of active site, have on-target anti-
bacterial activity, and have no side-effects on functionally equivalent human
enzymes. (Figure credit: Sorci et al.)Chemistry & Biology 16, August 28, 2009 ª2009 Elsevier Ltd All rights reserved ix
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The control of the structure of matter is a key goal of nanoscience, and
DNA is an exciting molecule for control because it forms program-
mable intermolecular interactions. Today, there is great interest in
the organization of one-dimensional rod-like species. Candidates
include biological microfilaments or microtubules as well as carbon
nanotubes or other inorganic nanotubes. The idea behind the work
by Wang et al. is that a DNA sheath can be used to organize its
contents by interacting with a two-dimensional DNA surface; e.g.,
a DNA crystal or an origami tile. The authors have prototyped this
approach by encapsulating a DNA double helix within a DNA sheath.
(Figure credit: Wang et al.)
Biomarkers for Celiac Sprue
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New tools are needed for managing celiac sprue, a life-long immune
disease of the small intestine caused by dietary gluten. In order to
tackle this issue, Bethune et al. designed gluten peptide analogs
that retain key properties of their pathogenic counterparts but that
are noninflammatory. In vitro and animal studies demonstrated the
utility of these analogs as biomarkers for detecting intestinal permeability changes as well as glutenase-catalyzed gastric detoxi-
fication of gluten. Accordingly, controlled clinical studies are warranted to evaluate the use of these peptide biomarkers in
diagnostic and therapeutic applications for celiac sprue and other diseases of genetic or infectious origin in which the gut barrier
is impaired.
Fatostatin: Of Mice and Diets
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Sterol regulatory element binding proteins (SREBPs) are transcription factors important in
lipogenesis. The study by Kamisuki et al. reports a small synthetic molecule (fatostatin)
that impairs the activation of SREBPs, thereby decreasing the transcription of lipogenic
genes. Experiments suggest that fatostatin inhibits the ER-Golgi translocation of SREBPs
through binding to their escort protein, the SREBP cleavage-activating protein (SCAP),
at a distinct site from the sterol-binding domain. Fatostatin blocked increases in body
weight, blood glucose, and hepatic fat accumulation in obese ob/ob mice, even under
uncontrolled food intake. Fatostatin may serve as a tool for gaining further insights into
the regulation of SREBP. (Figure from Kamisuki et al.)
From the Sea of Papua New Guinea
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Cyanobacteria have emerged as exceptionally rich sources of toxins, drug leads, and
pharmacological tool compounds. Using a neuropharmacological screening assay to
guide the process, a new type of natural product was isolated: a Papua New Guinea assemblage of two marine cyanobacteria,
as reported by Pereira et al. in this issue of the journal. The isolated compound, hoiamide A, derives from an interesting integration
of modified amino acid and polyketide synthase fragments, and extensive NMR was used to define its complete 3-dimensional
structure. Hoiamide A potently inhibits batrachotoxin binding to voltage-gated sodium channels (VGSC) via partial agonism at site
2 and could potentially be used as a probe of VGSC function.x Chemistry & Biology 16, August 28, 2009 ª2009 Elsevier Ltd All rights reserved
